dc.contributor.author | Soysal, Teoman | |
dc.contributor.author | Eskazan, Ahmet Emre | |
dc.contributor.author | Erbilgin, Yücel | |
dc.contributor.author | Ferhanoglu, Burhan | |
dc.contributor.author | Ozbek, Ugur | |
dc.date.accessioned | 2021-03-04T11:19:32Z | |
dc.date.available | 2021-03-04T11:19:32Z | |
dc.date.issued | 2011 | |
dc.identifier.citation | Eskazan A. E. , Soysal T., Erbilgin Y., Ozbek U., Ferhanoglu B., "Chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation are resistant to dasatinib: Is that true for all the patients?", LEUKEMIA RESEARCH, cilt.35, sa.9, 2011 | |
dc.identifier.issn | 0145-2126 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_71cacc48-ca69-410d-a618-802b18e5dca8 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/78341 | |
dc.identifier.uri | https://doi.org/10.1016/j.leukres.2011.04.025 | |
dc.language.iso | eng | |
dc.subject | Hematoloji | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Onkoloji | |
dc.subject | ONKOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | HEMATOLOJİ | |
dc.subject | Tıp | |
dc.title | Chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation are resistant to dasatinib: Is that true for all the patients? | |
dc.type | Makale | |
dc.relation.journal | LEUKEMIA RESEARCH | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 35 | |
dc.identifier.issue | 9 | |
dc.contributor.firstauthorID | 100113 | |